Displaying items 181-184 of 184 in total
With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.
Tesla's Q4 report shows a complex picture. Vehicle deliveries fell short, but record-breaking growth in the energy division hints at a major strategic shift.
European FinTech Multitude AG unveils its 2026 financial calendar, offering investors a clear roadmap amid strong growth and evolving market dynamics.
Facing an OSC probe and audit delays, the legal tech firm is now seeking court relief, raising red flags for investors about its governance and finances.
Get your daily brief delivered to your inbox every morning at 7am
